Mauna Kea is going nowhere fast - they will be close to saturating their potential markets. At DDW currently and overall interest in CLE in luminal gastroenterology does appear to be waning in the scientific sessions and discussions with others. Too time consuming for routine practice, and cost effectiveness analyses don't look particularly favourable.
Mauna Kea is going nowhere fast - they will be close to...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $167.0M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $12.03K | 60.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 19641 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 14975 | 2 |
View Market Depth
| Last trade - 15.59pm 15/08/2024 (20 minute delay) ? |
| OIL (ASX) Chart |